| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.093 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.092 | 0.6 |